Loading…
Sudarshan Pharma Industries (BSE 543828)₹35.84−4.09%Specialty Chemicals
At the end of the Sep 2026 quarter, Sudarshan Pharma Industries' shareholders were: promoters 57.80%, FIIs 21.92%, government 0.05%, public 20.23%. Promoter holding is down 1.12 percentage points from 58.92% a quarter earlier. FII holding is up 1.15 percentage points from 20.77% a year earlier. It had 1,251 shareholders.
As of · Company filings (shareholding pattern)
| Mar 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Promoters | 57.38% | 57.38% | 57.38% | 57.38% | 57.38% | 57.38% | 57.38% | 58.92% | 57.80% |
| FIIs | 1.39% | 13.05% | 18.43% | 19.47% | 20.77% | 19.76% | 19.93% | 19.36% | 21.92% |
| Government | 0.00% | 0.00% | 0.00% | 0.05% | 0.05% | 0.05% | 0.05% | 0.05% | 0.05% |
| Public | 41.23% | 29.57% | 24.19% | 23.10% | 21.80% | 22.81% | 22.64% | 21.67% | 20.23% |
| Number of shareholders | 914 | 788 | 1,213 | 1,328 | 1,384 | 1,408 | 1,347 | 1,232 | 1,251 |
| Holder | Category | Sep 2026 | Change (pp) |
|---|---|---|---|
| Sachin Vasantrai Mehta | Promoter | 27.80% | −0.53 |
| Hemal Vasantrai Mehta | Promoter | 26.98% | −0.52 |
| Century India Opportunity Fund Pc | FII | 3.17% | −0.06 |
| Saumik Ketankumar Doshi | Public | 2.81% | +1.20 |
| Eminence Global Fund Pcc- Eubilia Capital Partners | FII | 2.75% | +0.82 |
| Ebisu Global Opportunities Fund Limited | FII | 1.95% | +0.01 |
| Unbounded Opportunities Fund SPC –Alpha Investments SP | FII | 1.88% | New |
| Coeus Global Opportunities Fund | FII | 1.66% | −0.03 |
| North Star Opportunities Fund Vcc-Bull Value Incor | FII | 1.66% | 0.00 |
| Minerva Ventures Fund | FII | 1.58% | New |
| Bridge India Fund | FII | 1.57% | −0.03 |
| Nexpact Limited | FII | 1.50% | −0.32 |
| Pine Oak Global Fund | FII | 1.25% | New |
| Devangi Hemal Mehta | Promoter | 0.90% | −0.02 |
| Hemal V Mehta Huf . | Promoter | 0.65% | −0.01 |
| Sachin V Mehta Huf . | Promoter | 0.65% | −0.01 |
| Namrata Sachin Mehta | Promoter | 0.64% | −0.01 |
| Vasantray Ratilal Mehta | Promoter | 0.19% | −0.01 |
| Jatin Vasantrai Mehta | Promoter | 0.06% | −0.01 |
| Multitude Growth Funds Limited | FII | Exited | — |
Promoters held 57.80% of Sudarshan Pharma Industries at the end of the Sep 2026 quarter, up 0.42 percentage points from 57.38% a year earlier.
In the Sep 2026 quarter, foreign institutional investors (FIIs) held 21.92% (up 2.56 percentage points from 19.36% a quarter earlier) and domestic institutions (DIIs) held no reported stake.
Sudarshan Pharma Industries had 1,251 shareholders at the end of the Sep 2026 quarter, against 1,384 a year earlier.
Century India Opportunity Fund Pc (FII) held 3.17% at the end of the Sep 2026 quarter, the largest named holding outside the promoter group.